Upon recommendation by underwriters’ counsel, members of CRA’s accounting and advisory team assisted a US-based bio-technology company in advance of its IPO by advising on existing compliance procedures, tightening financial controls, and enhancing internal reporting, governance, and risk management functions. CRA team members recommended and implemented both qualitative and systems-based solutions designed to address regulatory requirements.
Navigating the intersection of innovation and regulation: Addressing fraud risks in the age of artificial intelligence (“AI”)
The rise of AI and generative artificial intelligence (GenAI) has been impactful in many industries, but there are inherent risks that organizations must...